FDX Capital Deal Announcement
September 30, 2013 - FDX Capital LLC, a member of FINRA & SIPC, is pleased to report that our client Seven Mile Capital Partners announced this morning that it has entered into a definitive agreement to acquire Microporous Products from Polypore International, Inc, a New York Stock Exchange listed company (NYSE:PPO) for $120 million. FDX Capital acted on behalf of Seven Mile Capital in placing equity provided by some of the family offices involved in the transaction. Polypore is selling its Microporous Products business unit as a result of an FTC ordered divestiture. The transaction is expected to close in the fourth quarter of 2013, subject to FTC approval.
Below are links to the press release issued by Seven Mile Capital Partners, and the article that appeared in today's online Wall Street Journal.
http://www.pehub.com/2013/09/30/seven-mile-acquire-microporous-polypore/
http://online.wsj.com/article/PR-CO-20130926-910463.html
Please contact Linda Shepro, Co-Managing Partner FDX Holdings LLC at 312-327-1221 lshepro@fdxcapital.com with questions or to discuss other opportunities in the FDX pipeline. The principals of Seven Mile will be joined by participating family offices at Family Office Exchange's 2013 Fall Forum on October 28 to discuss the transaction. To see an agenda for the Fall Forum visit the following link:
https://www.familyoffice.com/learning-events/forums/2013-fox-fall-forum
Disclaimer
The information contained in this document has been obtained from sources believed to be reliable; however, FDX Capital does not attest to its completeness or accuracy. The information contained herein is intended for informational purposes only and is not intended, nor should it be construed as a recommendation, investment advice, an offer to sell or buy, a solicitation, nor an endorsement by FDX Capital. Any securities referenced herein may be unsuitable for your risk tolerance. In reviewing this document related to a transaction we may be working on you are agreeing to keep all information and related discussions confidential pursuant to Regulation FD until a public announcement is made.